Supporting this finding, we also observed lower BMP9 mRNA levels in HCC cells than in normal liver cells from two different GEO datasets for HCC, and the decreased expression of BMP9 in HCC was further validated by IHC staining of clinical specimens. This evidence concerns the gene GDF2 and hepatocellular carcinoma.